stem cells

Trends in Stem Cell Research Funding: where do we go from here?

My post yesterday on the problems with the current system of stem cell funding generated a lot of interest from readers– more than a dozen left comments. Many of the comments were insightful even if readers disagreed on certain points. David Jensen also posted on an interesting piece on this issue in response to our […]

Trends in Stem Cell Research Funding: where do we go from here? Read More »

New Republican Governors Start Attack On Most Promising Stem Cell Research

Last Fall’s mid-term election brought into office several new Republican Governors who during their campaigns used strong, anti-embryonic stem (ES) cell research rhetoric. For example, then candidate for Governor of Wisconsin, Scott Walker (now the Governor) used some of the strongest language, which was ironic considering that human ES cells were first produced in Wisconsin

New Republican Governors Start Attack On Most Promising Stem Cell Research Read More »

Contagious cancer: the allograft your dog doesn’t want

Can one creature directly give another creature cancer? It appears so in dogs and that cancer is highly contagious. When we think about transplants of cells, we think about hospitals and high-tech equipment used to give patients stem cells or other types of cells to help treat them for a disease. Generally cancer patients are

Contagious cancer: the allograft your dog doesn’t want Read More »

Appeals court dismisses lawsuit against ES cell research, but this was a different lawsuit

A federal appeals court today threw out a lawsuit against federal funding of ES cell research. The lawsuit reportedly was filed on behalf of all cryopreserved embryos in the U.S. and the ruling was issued by the US Court of the Appeals of the 4th Circuit. While this decision does not directly have anything to

Appeals court dismisses lawsuit against ES cell research, but this was a different lawsuit Read More »

CIRM Appoints UC Davis Grad and Executive Med Director of Amgen as VP

CIRM announced today that it had appointed Ellen Feigal, M.D., to be its first VP for Research Development. Dr. Feigal will begin the job on Jan. 31. Dr. Feigal is a graduate of UC Davis Med School (where I am writing this from; go UC Davis SOM!) and is currently Executive Medical Director for Global

CIRM Appoints UC Davis Grad and Executive Med Director of Amgen as VP Read More »